Navigation Links
Prostate Cancer Radiotherapy Won't Affect Sexual Function
Date:10/29/2007

New high-dose technology targets tumor tissue, experts say

MONDAY, Oct. 29 (HealthDay News) High-dose precision radiation therapy doesn't harm the sexual function of prostate cancer patients, U.S. researchers say.

A team at Fox Chase Cancer Center in Philadelphia tracked 155 men with intermediate- to high-risk prostate cancer who underwent intensity-modulated radiation therapy (IMRT), a technique that more precisely targets the tumor.

"IMRT is revolutionizing how we treat men with prostate cancer, because it improves our ability to avoid normal tissue. As a result, more radiation dose can be delivered to the prostate by increasing the amount of radiation each day. Increasing the radiation used each day is particularly attractive, because it also shortens the treatment time by several days," study lead author Dr. Mark Buyyounouski, attending physician in the radiology department at Fox Chase, said in a prepared statement.

"We need to make sure there's a balance between risk and benefit, and sexual function is a major consideration. Fortunately, this study shows no decrease in sexual function from the higher doses of radiation," he said.

One group of men in the study received 2 Gy of radiation in 38 sessions over seven weeks, three days, while another group received 2.7 Gy in 26 sessions over five weeks, one day. At six months, one year, and two years after treatment, there were no significant differences in sexual function scores between the two groups.

The findings were expected to be presented Monday at the annual meeting of the American Society for Therapeutic Radiology and Oncology, in Los Angeles.

More information

The American Academy of Family Physicians outlines prostate cancer treatments.



-- Robert Pre
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
3. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
4. Better prostate cancer detection
5. Protective effects of tomatoes in prostate cancer
6. Early detection of prostate cancer
7. Prevention of Prostate Cancer
8. Low grade prostate cancer may be treated with mild treatment
9. British MPs Say Prostate Cancer Receives Low Priority in the NHS
10. Diagnosing Prostate Cancer is Harder in Obese Individuals
11. Fingerprinting prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015 Dr. David Knepp, a leading ... with Doctors on Liens to bring his ... rare for personal injury victims to have access to ... a lien basis. However, San Diego Chiropractic Group ... chiropractors, M.D., pain management physician, massage, and acupuncture to ...
(Date:3/2/2015)... GBCHealth, a prominent business coalition ... activities and investments in global health issues, today ... members to serve on the organization’s Board of ... Strategist and Co-founder of Partners In Health, and ... Abbasi, General Manager of Global Health and Medical ...
(Date:3/2/2015)... 2015 “ Wants and Needs ” ... AppWatch, which features the latest and coolest mobile applications ... a mobile technology expert and host of NewsWatch, conducted ... app helps people evaluate priorities. , Whether a person ... and Needs app. The app allows people to enter ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... offering gum reshaping procedures. Gum reshaping can involve one or ... or to regenerate lost gum tissue for a more even ... dark gum line treatment that can permanently lighten ... his total smile approach, which involves a personalized treatment plan ...
(Date:3/2/2015)... The Workgroup for Electronic Data Interchange (WEDI), ... health IT to create efficiencies in healthcare information exchange, ... Providers.” The white paper by WEDI’s ICD-10 Testing Subworkgroup ... testing by focusing on primary considerations and steps for ... October 1, 2015 implementation date. Download the white ...
Breaking Medicine News(10 mins):Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2
... Mayo Clinic researchers determined Math Learning Disorder (LD) is common ... to have Math LD than girls. The research also indicates ... a reading LD, a substantial percentage of children have Math ... through age 19 ranges from 6% to as high as ...
... or Lose it' starts three-year lifestyle campaign to fight osteoporosis ... fractures, a new report explains. , ,'One of the ... exercise,' noted Professor Helmut Minne, IOF Board member and author ... build and maintain strong bones, prevent falls and fractures and ...
... a collaborative work Scientists now been able to map the ... change the face of future medicine. ,The study called ... to chart genetic differences between 269 individuals that originate from ... East and Western Europe. The study involved more than ...
... Mayo Clinic researchers determined Math Learning Disorder (LD) is common ... to have Math LD than girls.//he research also indicates that ... reading LD, a substantial percentage of children have Math LD ... age 19 ranges from 6% to as high as 14%, ...
... Despite the initial efficacy of these therapies against ... Bortezomib (Velcade, formerly PS-341, Millennium, USA) is a ... // multicatalytic cellular enzyme whose activity entails ... pathway. , ,Currently, bortezomib, alone or in ...
... that Bulgaria is to ban the imports of live birds, ... countries reported suspected bird flu outbreaks. The first case of ... Balikesir province near the Aegean Sea in Western Turkey. Following ... are being slaughtered in order to prevent the spread of ...
Cached Medicine News:Health News:Math Learning Disorder Higher In Boys 2Health News:Want Strong Bones: Exercise And Eat Right! 2Health News:Math Learning Disorder Higher in Boys 2Health News:Bortezomib for salvage therapy against progressive myeloma 2
(Date:3/2/2015)... 2, 2015  BC Technical, the nation,s leading ... Eclipse Systems, a Nuclear Imaging service company providing ... of their ongoing vision to provide the best, ... BC Technical continues to expand their reach and ... add valuable resources and knowledge in addition to ...
(Date:3/2/2015)... 2, 2015  DURECT Corporation (Nasdaq: ... and the successful completion of a Phase 1 ... DUR-928.  DUR-928 is an endogenous, small-molecule, new chemical ... metabolic diseases such as nonalcoholic fatty liver disease ... organ injuries such as acute kidney injury (AKI).  ...
(Date:3/2/2015)... GERMANTOWN, Md., March 2, 2015  Intrexon Corporation ... synthetic biology, today announced its fourth quarter and ... Business Highlights and Recent Developments: , Acquired ... a new frontier in cellular therapeutics and other ... molecular engineering of food-grade microbes ( Lactococcus lactis ...
Breaking Medicine Technology:BC Technical Acquires Eclipse Systems 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24
... N.J., April 12, 2011 Novartis Pharmaceuticals Corporation ... Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) ... treatment of patients with advanced neuroendocrine tumors (NET) ... provided after presentation of data from the everolimus ...
... 2011 Havel,s market leading EchoStim® Echogenic Insulated ... to perform Peripheral Nerve Blocks (PNBs) using nerve ...  The new improved needle has more, brighter, easier ... giving even inexperienced practitioners the benefits of using ...
Cached Medicine Technology:Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
Antigenic Free Protein S, ELISA Method...
... Clotting Assay for ... the Functional Protein S ... of Factor Va Inhibition ... Human Plasma, free of ...
Colorimetric Assay of Protein C Activity by STA© Analyzers. Highly purified extract of Agkistrodon c. contortrix venom for specific activation of protein C, with an activator selected specially ...
Colorimetric Assay of Antithrombin III Activity by STA© Analyzers. Bovine thrombin ~12NIH units/mL, freeze-dried....
Medicine Products: